These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

796 related items for PubMed ID: 31118805

  • 1. Expression profiles and prognostic significance of RNA N6-methyladenosine-related genes in patients with hepatocellular carcinoma: evidence from independent datasets.
    Zhou Y, Yin Z, Hou B, Yu M, Chen R, Jin H, Jian Z.
    Cancer Manag Res; 2019; 11():3921-3931. PubMed ID: 31118805
    [Abstract] [Full Text] [Related]

  • 2. Contributions and Prognostic Values of N6-Methyladenosine RNA Methylation Regulators in Hepatocellular Carcinoma.
    Qi LW, Jia JH, Jiang CH, Hu JM.
    Front Genet; 2020; 11():614566. PubMed ID: 33519919
    [Abstract] [Full Text] [Related]

  • 3. N6-methyladenosine methylation-related genes YTHDF2, METTL3, and ZC3H13 predict the prognosis of hepatocellular carcinoma patients.
    Wang Y, Li T, Liu H, Liang Y, Wang G, Fu G, Takatsuki M, Qu H, Jing F, Li J, Jiang M.
    Ann Transl Med; 2022 Dec; 10(24):1398. PubMed ID: 36660669
    [Abstract] [Full Text] [Related]

  • 4. Identification and Validation of the N6-Methyladenosine RNA Methylation Regulator YTHDF1 as a Novel Prognostic Marker and Potential Target for Hepatocellular Carcinoma.
    Bian S, Ni W, Zhu M, Song Q, Zhang J, Ni R, Zheng W.
    Front Mol Biosci; 2020 Dec; 7():604766. PubMed ID: 33363211
    [Abstract] [Full Text] [Related]

  • 5. N6-methyladenosine associated prognostic model in hepatocellular carcinoma.
    Huang H, Bai Y, Lu X, Xu Y, Zhao H, Sang X.
    Ann Transl Med; 2020 May; 8(10):633. PubMed ID: 32566570
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. The Effect of m6A Methylation Regulatory Factors on the Malignant Progression and Clinical Prognosis of Hepatocellular Carcinoma.
    Zhao Z, Yang L, Fang S, Zheng L, Wu F, Chen W, Song J, Chen M, Ji J.
    Front Oncol; 2020 May; 10():1435. PubMed ID: 32974160
    [Abstract] [Full Text] [Related]

  • 9. The potential role of RNA N6-methyladenosine in primary Sjögren's syndrome.
    Xiao Q, Wu X, Deng C, Zhao L, Peng L, Zhou J, Zhang W, Zhao Y, Fei Y.
    Front Med (Lausanne); 2022 May; 9():959388. PubMed ID: 36465909
    [Abstract] [Full Text] [Related]

  • 10. Identification of METTL3 as an Adverse Prognostic Biomarker in Hepatocellular Carcinoma.
    Liu GM, Zeng HD, Zhang CY, Xu JW.
    Dig Dis Sci; 2021 Apr; 66(4):1110-1126. PubMed ID: 32333311
    [Abstract] [Full Text] [Related]

  • 11. RNA N6-methyladenosine methyltransferase-like 3 promotes liver cancer progression through YTHDF2-dependent posttranscriptional silencing of SOCS2.
    Chen M, Wei L, Law CT, Tsang FH, Shen J, Cheng CL, Tsang LH, Ho DW, Chiu DK, Lee JM, Wong CC, Ng IO, Wong CM.
    Hepatology; 2018 Jun; 67(6):2254-2270. PubMed ID: 29171881
    [Abstract] [Full Text] [Related]

  • 12. N6-methyladenosine-related Genomic Targets are Altered in Breast Cancer Tissue and Associated with Poor Survival.
    Liu L, Liu X, Dong Z, Li J, Yu Y, Chen X, Ren F, Cui G, Sun R.
    J Cancer; 2019 Jun; 10(22):5447-5459. PubMed ID: 31632489
    [Abstract] [Full Text] [Related]

  • 13. Methylation recognition protein YTH N6-methyladenosine RNA binding protein 1 (YTHDF1) regulates the proliferation, migration and invasion of osteosarcoma by regulating m6A level of CCR4-NOT transcription complex subunit 7 (CNOT7).
    Wei K, Gao Y, Wang B, Qu YX.
    Bioengineered; 2022 Mar; 13(3):5236-5250. PubMed ID: 35156522
    [Abstract] [Full Text] [Related]

  • 14. Identification of an m6A-Related Signature as Biomarker for Hepatocellular Carcinoma Prognosis and Correlates with Sorafenib and Anti-PD-1 Immunotherapy Treatment Response.
    Jiang H, Ning G, Wang Y, Lv W.
    Dis Markers; 2021 Mar; 2021():5576683. PubMed ID: 34221187
    [Abstract] [Full Text] [Related]

  • 15. The m6A readers YTHDF1 and YTHDF3 aberrations associated with metastasis and predict poor prognosis in breast cancer patients.
    Anita R, Paramasivam A, Priyadharsini JV, Chitra S.
    Am J Cancer Res; 2020 Mar; 10(8):2546-2554. PubMed ID: 32905518
    [Abstract] [Full Text] [Related]

  • 16. m6A-Related Genes Contribute to Poor Prognosis of Hepatocellular Carcinoma.
    Zou Y, Jiang G, Xie Y, Li H.
    Comput Math Methods Med; 2022 Mar; 2022():2427987. PubMed ID: 36339682
    [Abstract] [Full Text] [Related]

  • 17. HIF-1α-induced expression of m6A reader YTHDF1 drives hypoxia-induced autophagy and malignancy of hepatocellular carcinoma by promoting ATG2A and ATG14 translation.
    Li Q, Ni Y, Zhang L, Jiang R, Xu J, Yang H, Hu Y, Qiu J, Pu L, Tang J, Wang X.
    Signal Transduct Target Ther; 2021 Feb 23; 6(1):76. PubMed ID: 33619246
    [Abstract] [Full Text] [Related]

  • 18. N6-Methyladenosine RNA Methylation Regulator-Related Alternative Splicing (AS) Gene Signature Predicts Non-Small Cell Lung Cancer Prognosis.
    Zhao Z, Cai Q, Zhang P, He B, Peng X, Tu G, Peng W, Wang L, Yu F, Wang X.
    Front Mol Biosci; 2021 Feb 23; 8():657087. PubMed ID: 34179079
    [Abstract] [Full Text] [Related]

  • 19. Systematic analysis of the expression profile and prognostic significance of m6A regulators and PD-L1 in hepatocellular carcinoma.
    Kong F, Wang K, Wang L.
    Discov Oncol; 2022 Nov 25; 13(1):131. PubMed ID: 36434140
    [Abstract] [Full Text] [Related]

  • 20. Cross talk between RNA N6-methyladenosine methyltransferase-like 3 and miR-186 regulates hepatoblastoma progression through Wnt/β-catenin signalling pathway.
    Cui X, Wang Z, Li J, Zhu J, Ren Z, Zhang D, Zhao W, Fan Y, Zhang D, Sun R.
    Cell Prolif; 2020 Mar 25; 53(3):e12768. PubMed ID: 31967701
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 40.